Primary outcome analysis. RR reduction of recurrent placenta-mediated pregnancy complications (any PE, placental abruption, SGA child [<10th percentile] or pregnancy loss >20 weeks) with LMWH in women with prior placenta-mediated pregnancy complications (PE, SGA child [<10th percentile], late pregnancy loss [>12weeks] or placental abruption).